The urokinase-type plasminogen activator receptor (uPAR) focuses at the cell surface the activation of pro-uPA and, hence, the formation of plasmin, thus enhancing directional extracellular proteolysis. To characterize the transcriptional regulatory mechanisms that control receptor expression, we have cloned an uPAR DNA segment containing upstream regulatory sequences from both the human and murine genomes. We report that a proximal promoter, contained within 180 bp from the major transcription start sites of the T HE MIGRATION OF normal and neoplastic cells across tissue barriers is regulated by plasmin-mediated degradation of extracellular matrix proteins, as well as activation of factors such as hepatocyte growth factor and transforming growth factor (TGF)-P. ' Activation of plasminogen and other factors is mediated by urokinase-type plasminogen activator (uPA), which is held on the cell surface by a specific membrane receptor (uPAR).' Three inhibitors, PAI-1, PAI-2, and PN-1, can bind the uPA moiety of this complex to regulate its a~t i v i t y .~.~ In addition to recruiting migrationregulatory factors at specific areas of the pericellular space, the receptor also exerts the action to unload stable uPAinhibitor complexes from the cell surface by a mechanism of internalizatioddegradation.' This process also involves a second receptor protein identified as the a2-macroglobulin receptor.'.6 The uPAR mRNA encodes a protein containing 3 13 amino acids plus the signal which is processed during biosynthesis by glycosylation, carboxy-terminal processing, and addition of a glycosyl-phosphatidylinositol (GPI) anchor.'.'' The polypeptide sequence exhibits three regions of internal homology with a distinctive distribution of cysteines and disulphide bonds common to other GPIanchored proteins of the LY6klapid venom toxins superfam- 
human uPAR gene, drives basal transcription. This region lacks TATA and CAAT boxes and contains relatively GC-rich proximal sequences. A subregion of this sequence, highly conserved between human and murine genes, contains most of the promoter activity and is specifically bound by HeLa nuclear proteins, one of which belongs to the SP1 class.
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ily.""' The three domains contain approximately 90 amino acids each, and the amino terminal domain contains ligandbinding a~t i v i t y . '~. '~ T h e uPAR is expressed in a variety of normal and neoplastic cells. Its expression is influenced by a number of hormones and growth factors that may superimpose a cell type-specific modulation over basal receptor expression. '8-23 The expression of uPA, PAI-I, and PAI-2 also exhibit similar characteristics, thus suggesting some kind of connection between regulatory mechanisms of the components of the plasminogen activation sy~tem.*~,~' Like uPA, the uPAR is found at very high levels in human tumors where it is localized at the invading edge.""' To investigate the mechanisms that regulate transcription of the uPAR gene, we have isolated upstream DNA sequences, identified the transcription start sites, and defined a minimal promoter region required for basal transcription of the human uPAR gene. We have found that 18 1 bp upstream from the transcription start site contain substantial basal promoter activity and are bound by multiple nuclear factors, including SPI, and enclose a region highly conserved between human and murine uPAR genes.
MATERIALS AND METHODS

Cloning and nucleotide sequence determination of human uPAR 5' $anking region.
A human leukocyte genomic library in XEMBL3 phage (obtained from Clontech, San Diego, CA) was screened using the human uPAR cDNA as hybridization probe. Three identical recombinant phage clones containing uPAR sequences were identitied from IO6 plaques. Five DNA fragments, representing the whole insert, were separated from the phage vector following digestion with Sal I and BamHI and subcloned into pEMBL8 plasmid vector."
The DNA insert was mapped by digestion with different restriction enzymes and hybridized to cDNA fragments and to a 40-bp long synthetic oligonucleotide covering the 5 ' end of the published cDNAX (data not shown). The nucleotide sequence of the human uPAR genomic clone was determined on both strands of the DNA by the dideoxynucleotide chain termination method.3' Oligonucleotide primers were synthesized with an Applied Biosystems DNA synthesizer (Applied Biosystems, Foster City, CA). Oligonucleotides for DNA sequencing were chosen from the sequence of the uPAR UROKINASE RECEPTOR PROMOTER 625 A total of 50 pg of total RNA isolated from PMA-treated U937 cells and 25 pg of RNA from PMA-treated HeLa cells (PMA concentration was 100 ng/mL for 12 and 6 hours, respectively) were hybridized using 2 X lo4 cpm of probe in 80 PL for 16 hours at 42°C in 50% formamide, 40 mmol/L Pipes pH 6.7, 0.4 mot/L NaCl, 1.0 mmol/L EDTA. After dilution with RNase buffer, the mixture was digested with 40 pg/ mL RNase A and 1,000 U/pL RNase T (Boehringer Mannheim, Germany) at 32°C. Products were resolved on 8% denaturing polyacrylamide gels. Construction of huPAR-CAT expression vectors. A 2.3-kb SphIl NruI genomic fragment, containing the 5' flanking region extending up to +46 into exon 1, was first cloned into the Sph VSma I sites of pSP73 vector (Promega) to produce p5'R/73 plasmid. p5'R/73 was digested with Sph I and Cla I sites and the 2.3-kb insert upstream of the AUG was then ligated into Sph WAcc I sites of pCAT-Basic vector (Promega) to yield construct Cl (see Fig 3) . A 450-bp Xba I fragment from Cl was inserted in either orientation in the Xba I site of pCAT Basic vector, to generate C2 and C3. Constructs C4 and C5 were obtained by insertion of PCR-amplified fragments containing sequences +41 to -181 and +41 to -71, respectively, in the Xba I site of pCAT Basic vector. All constructs were verified by dideoxy DNA sequencing. 3' deletions (C6, C7, and C8) were obtained by exonuclease III digestion: a Psf I genomic fragment containing the first exon, part of the first intron and upstream sequences up to -1275 ( Fig 1A) hours posttransfection, the secreted growth hormone was measured and cells were harvested. CAT assays were performed as described."' After heating to 65°C for 10 minutes, 5-50 PL of cell extract was incubated with 300 pmol/L n-butyryl coenzyme A and 0.2 $i of "'C-chlomamphenicol (Du Pont, Wilmington, DE) in 100 PL of 250 mmol/L Tris-HCl pH 8. After 2 hours at 37°C the reaction products were isolated by extraction with 200 PL of xylene, back extracted twice with 200 PL of 10 mmoliL Tris-HCl (pH 7.5)-l mmol/L EDTA, mixed with 5 mL of scintillation fluid, and radioactivity was counted in a Beckman scintillation counter (Beckman Instruments, Irvine, CA). Protein concentrations were determined with the Bradford protein assay (Bio-Rad, Richmond, CA) and the results of CAT assays were normalized to 50 @g protein and to the secreted HGH as determined with a radioimmunoassay kit (Alegro HGH; Nichols Institute Diagnostic). CAT activities of the samples were in the linear range of the assay. Each experiment was performed at least three times and in duplicate. The Drosophila Melanogaster Schneider line 237 was cultured at 27°C in Schneider's Drosophila Medium (GIBCO, Grand Island, NY) supplemented with 10% fetal bovine serum and penicillin/streptomycin (GIBCO).
A total of 1 X 10' cells were seeded in 100~mm dishes and transfected 24 hours later with the calcium phosphate precipitation method using 1 /lg of pCHll0 (Pharmacia), 5 pg of promoter-CAT plasmid and P.$?PI or P%O." Harvesting was 48 hours posttransfection. Transfection efficiency was normalized to P-galactosidase activity. Protein concentration of the extracts was measured, and 50 pg were analyzed for CAT enzyme activity using (14C) Chloroamphenicol and thin layer chromatography. sized by PCR amplification (upstream primer: S'CGGGTCCCAClTTAGGAAGAGAGAGAACTGG3'; downstream primer, S'CTCAGGAAGGAGGCAGTGCCC3' labeled with y"P-ATP). The labeled PCR fragment was purified in 10% nondenaturing polyacrylamide gel and 2.5 ng were used for each binding reaction. Oligonucleotides used as probes were end-labeled with T4 polynucleotide kinase and y"P-ATP.
annealed and purified on a 15% nondenaturing polyacrylamide gel. Binding reactions (20 pL) contained 50,000 cpm of probe (0.1 ng), 10 pg of Poly(d1-dC) in 10 mmol/L HEPES buffer containing 10% glycerol, I O 0 mmol/L KCI.
10 mmol/L MgClz, and 1 to 6 yg of nuclear extract. Incubations were for 30 minutes at room temperature. Free and bound probe were separated by electrophoresis in nondenaturing 4% polyacrylamide gel (acrylamidehis ratio 80:l) using 0.5 X Tris-borate-EDTA. Gels were dried and subjected to autoradiography. Double-stranded oligonucleotides were (upper strand): SPI: S'GATCGATCGGGG-CGGGGCGATC3'; APl : S'CTAGTGATGAGTCAGCCGGATC3'. AP2: 5' GATCGAACTGACCGCCCGCGGCCCGT3'. Oligo A:
5'GGGAGGAGTCC~GGGGCCACAAAACTGCCTCClTCCT3'
Oligo C: S'CTGGGGCTGACTCGCTCTCGC3'.
DNase I footprinting ana/ysis. A 5' "P-labeled 238-bp fragment (-141 to +97) was incubated in 50 pL with 50 ng of human recombinant SPl (Promega) or 70 yg of HeLa nuclear extracts for 30 minutes at m m temperature in binding buffer (10 mmol/L Hepes buffer, 10% glycerol, 1 0 0 mmol/L KCI. 10 mmol/L MgC12). DNase I (Promega) was added at 0.04, 0.09, and 0.15 UIpL in 20 yl of buffer containing CaClz (5 mmol/L) and MgCI? (10 mmol/L). Digestion was for 1 minute at room temperature and was stopped by addition of EDTA, proteinase K, yeast tRNA as carrier, and SDS (0.1%). After 10 minutes at 37°C. samples were extracted with phenolkhlorophorm and precipitated. Products were separated in 8% denaturing polyacrylamide gel along with G+A sequencing reaction.'"
RESULTS
The genomic structure of the j r s t domain qf uPAR. We have isolated sequences encoding the human urokinase receptor (uPAR) gene from a human genomic leukocyte library in phage AEMBL-3 (see Materials and Methods section).
The positive clone AuPAR-l, carrying a 14-kb insert, was analyzed by restriction mapping and Southern blot hybridization using as probes a set of fragments generated from the previously cloned cDNA (see Materials and Methods) ( Fig  1A) . Adjacent and overlapping subfragments of the DNA insert were subcloned in plasmid vectors and sequenced. showing that AuPAR-l contained the 5' end of the uPAR gene. We, therefore, determined the intron-exon junctions in this region and characterized by restriction mapping and sequencing the 5' flanking region (Fig 1A) . Comparison of the sequence obtained with that of the cDNA showed the presence of sequences flanking the 5' end of the uPAR cDNA, coding sequences including the cDNA up to the codon for residue gly104 and intervening sequences 3' of this codon (Fig 1A) . The coding sequences covered the signal peptide and the whole first domain of uPAR and were arranged in three exons: exon I included the transcription start sites (see below), the 5"untranslated end of the cDNA and most of the signal peptide extending through the codon for the 19th residue (ala) in the signal peptide; exon 2 ( 1 1 1 bp) encoded from residue 20 in the signal peptide through the codon for residue glu34 of the mature protein; exon 3 ( 1 4 4 bp) contained sequences throughout the codon for residue gly82 of the mature protein (Fig IB) . The size of the intervening sequences was 2.6 kb for intron 1 and 2.4 kb for intron 2. The 3' portion of the phage insert ended with about 5 kb not containing coding sequences and, hence, probably belonging to intron 3, separating the third and fourth exons. The sequences at the intron-exon junctions are reported in Table 1 .
IdentiJication qf the transcription initiation site. The cDNA for uPAR contains a 45 nucleotides-long untranslated region upstream of the ATG initiation codon.* To identify the 5"flanking region of the uPAR gene, it was necessary to define its transcription initiation site. For this we used RNA of PMA-treated U937 monocytic cells and HeLa cells that both express high levels of uPAR.'832' Oligonucleotide primers corresponding to two distinct segments of the uPAR mRNA were separately hybridized to either total or poly A+ RNA from U937 cells and incubated with reverse transcriptase. Primer extension products were analyzed on the same gel along with the corresponding uPAR genomic DNA or with an unrelated DNA ladder (Fig 2) . The extension products could be identified from their size. Primer P1 corre- sponds to the sequence + 122 to + 141, primer P2 to +41 to +72 of the cDNA sequence.' Figure 2B shows that primer P1 was extended to products of roughly 145 nucleotides in length, while primer P2 was extended to products of about 75 nucleotides (Fig 2C) . This result indicates that the extension of both primers ended at comparable positions on the uPAR genomic sequence and that the major transcription initiation site resided only three to six nucleotides upstream 
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For personal use only. on October 22, 2017. by guest www.bloodjournal.org From l protected fragment of the 5' terminus of the cDNA clone. Moreover, the products obtained with primer P2 were resolved as a group of six bands mapped in a sequence of 16 nucleotides (see Fig  2C) . Figure 2D shows the DNA sequence of the flanking region of the human uPAR gene with the identification of the various transcription start sites. The most upstream of the start sites, an A following a C, was arbitrarily given the position + 1. This site is located six nucleotides upstream of the 5' terminus of the cDNA and 52 nucleotides upstream of the translation initiation codon. A minor extension product of 170 nt was also noticed with primer P1 on total RNA (Fig 2A indicated with both properties of genes that, like uPAR, lack the TATA The promoter of the human uPAR gene. The XuPAR-I insert contained about 4.5 kb upstream of the first uPAR exon (Fig 1A) . Within 1.5 kb upstream (Fig IB) , we identified two Alu-type repetitive elements in the distal portion (enclosed in boxes , Fig 1 B) . To identify the promoter region, we fused to the bacterial CAT gene the sequences from -2.3 kb to +46 and the sequences from -0.4 kb to +46 and measured CAT activity after transfection in HeLa In four distinct sets of experiments, we observed that transfection with constructs carrying 2.3 kb (construct C l ) or 0.4 kb (construct C2) of upstream sequences elicited a 24-fold and 35-fold higher activity, respectively, than the promoterless vector (Fig 3) . Because these two constructs drove comparable CAT gene expression, the promoter must be contained within 0.4 kb from the transcription start site. Furthermore, the activity of this region is orientation-dependent (construct C3). We also noticed that construct C2 was 1.5-fold more active than construct C l , and this might indicate the presence, upstream of position -401, of a weak negative regulatory element that remains to be characterized. A better resolution of the active region was obtained using construct C4 ending at position -181, which showed 83% of the activity of construct C2. The role of proximal sequences was confirmed by 3' deletions constructs (C6-C8) which showed eightfold reduction in activity. Construct C9 and C10, lacking sequences from -401 to +46, did not show any activity. We conclude from these data that 18 1 nucleotides upstream of the transcription start site account for most of the transcription-promoting activity and that sequences -401 to -182 contribute weakly to the overall activity. By contrast, more upstream sequences do not contribute any activity, at least under basal conditions (see also constructs C9 and C10). Within the proximal 0.4 kb, we observed a sequence of 240 nucleotides containing 63% GC, proximal to the transcription start site. This region lacks TATA and CAAT boxes and perfect matches to typical SP1 consensus elements, although contains five SPI -like sequences, each with a single mismatch: three copies of the sequence GGGAGG are observed at position -44 to -39 and between nucleotides -102 and -88, and the sequences GGGCCG and GGGCTG are observed at positions -175 to -170 and -73 to -68, re~pectively.~' A PEA3 consensus sequence is present more upstream (-241 to -248). The most proximal 5"flanking 181 bp contain one mismatched AP2-like sequence (-168 to -161), one AP1 consensus sequence (-182 to -176), a combined Glucocorticoid Responsive/APl -like Element (-69 to -63) (Fig le) . Alignment of the human promoter with the corresponding murine shown in Fig 4, For 
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shows 68% identity in a region of about 135 nucleotides, and that one of the human transcription start sites coincides with the major transcription start site determined with murine cells mRNA." Both the human and mouse promoters lack TATA boxes and present a moderately high GC content in the proximal 134 nucleotides (66%). The mouse sequence contains multiple canonical SPl binding sites and a perfect match with an APl site (TGACTCA). Beyond this area of homology, only another APl site is conserved between human and mouse (position -182 to -176 in the human sequence).
In vitro protein DNA interactions at the uPAR gene promoter. To identify nuclear factors that interact with the human uPAR promoter, we used nuclear extracts from HeLa cells. Binding assays were done with a 256-bp fragment (-4 to -260) encompassing the most active promoter region. Large amounts of specific DNA fragment were used in the binding reactions to resolve individual complexes formed with this long probe, presumably containing multiple protein binding sites. Under these conditions, one major and six minor complexes were resolved in native polyacrylamide gel using HeLa nuclear extracts (Fig 5, lane l) . These complexes were observed reproducibly and appear to be specific, as they were all competed out with excess unlabeled fragment (lanes 2 and 3), but not with Escherichia coli DNA fragments (lanes 10 and ll), or poly d(IC) (not shown). Complex 3 (indicated with an asterisk in Fig 5 ) was only partially selfcompeted, but was not at all competed by nonspecific competitors (Fig 5, lanes 10 and 11) or oligonucleotides bearing API, AP2, and SPI consensus sequences (Fig 5, lanes 4 to  9) . Complexes 2 and 4 (indicated with arrows) were only competed in the presence of excess consensus SPI oligonucleotide (Fig 5, lanes 8 and 9) , thus indicating the binding of SP1-like factors to the mismatched SPI sequences. Complexes 1, 3, 5, 6, and 7 were not competed by any of the consensus oligonucleotides tested. In particular, oligonucleotides bearing API and AP2 consensus sequences did not compete any of the seven complexes (Fig 5, lanes 4 to 7) . Using a double-stranded oligonucleotide bearing sequences proximal to the transcriptional start site from -44 to -6, we observed that complex 5 was specifically competed (data not shown). Furthermore, an oligonucleotide containing sequences from -44 to -6 (oligo A) produced a specific complex in electrophoretic mobility shift assays (Fig 6) . IdentiJcation of the SPI transcription factor binding sites in the uPAR minimal promoter. The huPAR promoter resembles many other mammalian promoters lacking a proximal TATA element that have been shown to require SPI for transcriptional activity."' DNase1 protection assay with recombinant SPI showed three distinct footprintings between nucleotides -125 and -24 (Fig 7) , comprised within the most active region and containing two noncanonical SPI sites (GGAG motif). We note that this motif has been shown to be bound by SPI in the early promoter of the glia-cell specific virus JC.'" When HeLa nuclear extracts were used for footprinting analysis, we observed protections at positions -93 to -73 (site l), -70 to -45 (site 2). -44 to -37 (site 3), and -29 to -19 (site 4). Of these, only sites I and 3 were similar, although not exactly identical, to the protections observed with recombinant SPI. Site 4 is comprised within the sequence of oligo A, which has been shown above, to be bound by a HeLa nuclear factor. A comparison of the footprints observed with pure recombinant SPI and with HeLa nuclear extracts is in Fig 7C. SPI activation of the uPAR promoter in Schneider cells. As a preliminary step to establish a functional role of SPI in the activity of the basal promoter, we cotransfected Drosophila Schneider cells that lack endogenous SP137 with hu-PAR-CAT constructs C2 (-401 to +46) or C7 (-401 to -227) and with a SPI expression plasmid (Fig 8) . In this experiment, both constructs exhibited activity depending on SPI expression (no activity was detected in control transfections with expression plasmid alone), thus suggesting that SPI can drive transcription from the uPAR promoter. Construct C7 only showed 2.5-fold lower activity than construct C2, probably owing to the presence of residual SP1 sites between positions -227 and -401.
DISCUSSION
The uPAR gene belongs to the Ly-6/elapid venom toxins multigene family, including genes for lymphoid cell antigens, and snake venom toxins. Members of this family are attached to the plasma membrane via a glycosyl phosphatidyl-inositol anchor. The sequence of the uPAR protein suggests the presence of three repeated structural domains with the amino-terminal domain having ligand-binding activity." Unlike uPAR, members of the Ly6-elapid venom toxins superfamily are single domain polypeptides.".'"" The structural homology among the members of this superfamily is defined on the basis of the conserved cysteine spacing and disulphide bond distribution, which has been determined for the amino terminal ligand-binding domain of uPAR, for CD59 and for the venom toxin, whose crystal structure has also been deter~nined.".'~ The sequence of the uPAR genomic DNA shows that the signal peptide is encoded by a separate exon and that there is no untranslated exon, unlike members of the Ly-6 gene family. The uPAR ligand-binding domain is encoded by two exons (see Fig IA) . This basic two-exon structure, also described for the single domain proteins of the superfamily, is most probably the ancestral domain from which different members of the superfamily have evolved. Transcription from the uPAR gene initiates at several sites in proximity of the 5' end of a previously characterized uPAR cDNA clone.' Consistent with multiple transcription initiation sites, the 5' flanking sequences of the uPAR gene lacks a TATA box that usually determines transcription initiation from a single major site. Primer extension and RNase protection experiments gave no evidence of other upstream initiation sites. A proximal basal promoter was contained in a region of 401 bp from the transcription start site and drove expression of uPAR-CAT fusions after transfection in HeLa cells. Deletion of the region encompassing the transcription start sites led to a strong reduction of CAT activity. These deletions still had some residual activity, which may depend on more upstream sequences (C6-C8); however, construct C9, missing altogether the -401 to +46 region, is totally devoid of activity. Transfection experiments overall showed that most of the activity is contained within 181 bp. There is a high sequence conservation of human and murine genes in the 135 nucleotides, which include the transcription start sites, thus suggesting the functional importance of this promoter domain. In the absence of a TATA box, transcriptional activation may function through SPI bound to GC rich sequences.4"'" It has been proposed that SPI might recruit the TFIID complex and RNA polymerase I1 via an intermediate tethering factor?' Alternatively, the 
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I * * I I 1 I l I TATA binding component of the TFIID complex might interact with sequences around position -30, even in the absence of TATA motif, although with a low-affinity, and SPI might help to stabilize this interaction." The region surrounding the transcription start site may be bound by nuclear proteins that recognize an Initiator (Inr) elethere is no universal consensus sequence motif for Inr, some sequence similarities exist, and they have allowed grouping of distinct Inr sequences:' The human uPAR transcriptional initiator site exhibits a partial match to the DHFR Initiator element that binds a factor termed HIPI (house keeping initiator protein)." The simultaneous binding of HIPI and of SPI has been shown to be sufficient for accurate transcription initiation from the DHFR gene?7 We have investigated the binding of HeLa nuclear proteins to uPAR promoter. ment..'.ss. , (for reviews, see Weiss and Reinberg4*). Although
Our data indicate that SPI binds to this region as confirmed by DNase footprinting with purified SPI and HeLa nuclear extracts. The role of SPI in promoter activity was also confirmed by cotransfection of Drosophila Schneider cells (which lack SPI."). showing that the effect was dependent on the number of SP1-binding sites in uPAR-reporter gene.
At least another factor, distinct from SPI, binds in proximity of the transcription initiation site (sequences -44 to -6) of both human and murine promoters. uPAR is transcriptionally induced by PMA and TGFPI treatment in human U937 and A549 cells Moreover, uPAR levels appear to depend on the level of expression of uPA." Therefore, it is interesting to note the presence in the human and mouse proximal promoter of consensus binding sites for transcription factors API, PEA3, and NFkB. It is possible that promoter specificity, inducibility, and strength are generated by appropriate interactions between multiple DNA-binding proteins within a short proximal regulatory sequence. Some of these sites may confer cell type-restricted expression, whereas others may be active ubiquitously or confer inducibility. Such complexity could account for different modulatory effects of hormones, growth factors, and cytokines in different cell types during pathologic or physiologic conditions requiring turnover of the extracellular matrix.
